Genus Revenue

Genus had revenue of 335.60M GBP in the half year ending December 31, 2025, with 0.60% growth. This brings the company's revenue in the last twelve months to 672.00M, up 0.06% year-over-year. In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M with 0.60% growth.

Revenue (ttm)

672.00M

Revenue Growth

+0.06%

P/S Ratio

2.29

Revenue / Employee

210.66K

Employees

3,190

Market Cap

1.54B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	672.80M	4.00M	0.60%
Jun 30, 2024	668.80M	-20.90M	-3.03%
Jun 30, 2023	689.70M	96.30M	16.23%
Jun 30, 2022	593.40M	19.10M	3.33%
Jun 30, 2021	574.30M	22.90M	4.15%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Oxford Nanopore Technologies	223.90M
Oxford Biomedica	168.74M
Avacta Group	113.00K
PureTech Health	4.66M
Scancell Holdings	4.71M
Bioventix	12.54M
Faron Pharmaceuticals Oy	1.14M
4basebio	1.78M

Revenue Rankings

Genus News

2 months ago - Genus Power Surpasses 26 Million Smart Meter Deployment Worldwide, Reinforcing Leadership in End-to-End Advanced Metering Solutions - PRNewsWire
3 months ago - UK animal genetics firm Genus surges on annual profit forecast upgrade - Reuters
8 months ago - British animal genetics firm Genus surges on strong annual profit growth - Reuters
1 year ago - UK's Genus secures FDA approval for PRP gene edit; shares soar - Reuters

More News